Quantessence Capital’s Steris STE Stock Holding History

Quantessence Capital’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,300	Closed	-$295K	–	410
2025 Q1	$295K	Buy	+1,300	New	+$286K	0.07%	239

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Quantessence Capital's STE Position: Q2 2025 in Review

Quantessence Capital sold out of Steris (STE) in Q2 2025, closing a stake of 1,300 shares — an estimated $295K sold.

Quantessence Capital first reported a position in STE in Q1 2025 and held it in 1 quarter. The position peaked at $295K in Q1 2025. 834 funds tracked by Wall St. Rank hold STE as of Q2 2025.

Quantessence Capital reported no remaining Steris position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 1,300 Steris shares in Q2 2025, an estimated $295K.
Quantessence Capital first reported a position in Steris in Q1 2025 and held it in 1 quarter.
Quantessence Capital's Steris position peaked at $295K in Q1 2025.
834 funds tracked by Wall St. Rank held Steris as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.